Collegium Pharmaceutical (COLL) Revenue (2014 - 2026)
Collegium Pharmaceutical (COLL) revenue from Mar 31, 2014 to Mar 31, 2026. The TTM Collegium Pharmaceutical (COLL) revenue is $796M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Collegium Pharmaceutical (COLL) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +19.88% |
| 3 Years TTM | +14.90% |
| 5 Years TTM | +19.91% |
Annual Revenue change of Collegium Pharmaceutical (COLL)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $194M | -75.21% |
| 2025 | $781M | +23.62% |
| 2024 | $631M | +11.41% |
| 2023 | $567M | +22.17% |
| 2022 | $464M | +67.56% |
| 2021 | $277M | -10.69% |
| 2020 | $310M | +4.49% |
| 2019 | $297M | +5.81% |
| 2018 | $280M | +884.59% |
| 2017 | $28M | +1565.50% |
| 2016 | $1.71M | -488.64% |
| 2015 | -$440K | N/A |
| 2014 | $0 | N/A |
| 2013 | $0 | N/A |
Comparison Collegium Pharmaceutical (COLL) five years revenue CAGR with competitors
Collegium Pharmaceutical (COLL) five years revenue CAGR is 19.91%.